Literature DB >> 9371555

Hygromycin B resistance mediates elimination of Leishmania virus from persistently infected parasites.

Y T Ro1, S M Scheffter, J L Patterson.   

Abstract

A series of pX63-HYG derivatives encoding Leishmania RNA virus 1-4 (LRV1-4) sequences were electroporated into cells of Leishmania strain M4147, a virus-infected strain of L. guyanensis. After 6 weeks of drug selection (hygromycin B), transfected parasites lacked detectable quantities of viral genomic double-stranded RNA, viral capsid protein, and RNA-dependent RNA polymerase (RDRP) activity. Evidence of viral infection was not recovered upon removal of the drug. While viral RNA transcripts were produced from electroporated expression vectors, as determined by reverse transcription-PCR, viral antigens were not detected, suggesting that the antiviral effects of hygromycin B are mediated through translation inhibition. A short-term selection study suggests that the LRV1-4 elimination may not only be a function of hygromycin B as a protein synthesis inhibitor but also possibly related to the mechanism of hygromycin B resistance in Leishmania strains.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9371555      PMCID: PMC230199     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Hygromycin B inhibits synthesis of murine coronavirus RNA.

Authors:  G Macintyre; D E Woods; R Anderson
Journal:  Antimicrob Agents Chemother       Date:  1991-12       Impact factor: 5.191

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Relationship between membrane integrity and the inhibition of host translation in virus-infected mammalian cells. Comparative studies between encephalomyocarditis virus and poliovirus.

Authors:  J C Lacal; L Carrasco
Journal:  Eur J Biochem       Date:  1982-10

4.  Effects of edeine, hygromycin B and alpha-Sarcin on influenza virus reproduction.

Authors:  A I Klimov
Journal:  Acta Virol       Date:  1981-05       Impact factor: 1.162

5.  Simultaneous transient expression assays of the trypanosomatid parasite Leishmania using beta-galactosidase and beta-glucuronidase as reporter enzymes.

Authors:  J H LeBowitz; C M Coburn; S M Beverley
Journal:  Gene       Date:  1991-07-15       Impact factor: 3.688

6.  Molecular cloning and analysis of yeast gene for cycloheximide resistance and ribosomal protein L29.

Authors:  H M Fried; J R Warner
Journal:  Nucleic Acids Res       Date:  1982-05-25       Impact factor: 16.971

7.  Synthesis of viruslike particles by expression of the putative capsid protein of Leishmania RNA virus in a recombinant baculovirus expression system.

Authors:  T L Cadd; J L Patterson
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

8.  Plasticity in chromosome number and testing of essential genes in Leishmania by targeting.

Authors:  A K Cruz; R Titus; S M Beverley
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-15       Impact factor: 11.205

9.  Successful transient introduction of Leishmania RNA virus into a virally infected and an uninfected strain of Leishmania.

Authors:  T C Armstrong; M C Keenan; G Widmer; J L Patterson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

10.  On the membrane cytopathology of mouse hepatitis virus infection as probed by a semi-permeable translation-inhibiting drug.

Authors:  G Macintyre; C Kooi; F Wong; R Anderson
Journal:  Adv Exp Med Biol       Date:  1990       Impact factor: 2.622

View more
  10 in total

1.  Antiviral screening identifies adenosine analogs targeting the endogenous dsRNA Leishmania RNA virus 1 (LRV1) pathogenicity factor.

Authors:  F Matthew Kuhlmann; John I Robinson; Gregory R Bluemling; Catherine Ronet; Nicolas Fasel; Stephen M Beverley
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-17       Impact factor: 11.205

2.  Concentration of 2'C-methyladenosine triphosphate by Leishmania guyanensis enables specific inhibition of Leishmania RNA virus 1 via its RNA polymerase.

Authors:  John I Robinson; Stephen M Beverley
Journal:  J Biol Chem       Date:  2018-03-06       Impact factor: 5.157

3.  Tilting the balance between RNA interference and replication eradicates Leishmania RNA virus 1 and mitigates the inflammatory response.

Authors:  Erin A Brettmann; Jahangheer S Shaik; Haroun Zangger; Lon-Fye Lye; F Matthew Kuhlmann; Natalia S Akopyants; Dayna M Oschwald; Katherine L Owens; Suzanne M Hickerson; Catherine Ronet; Nicolas Fasel; Stephen M Beverley
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-18       Impact factor: 11.205

4.  Viral discovery and diversity in trypanosomatid protozoa with a focus on relatives of the human parasite Leishmania.

Authors:  Danyil Grybchuk; Natalia S Akopyants; Alexei Y Kostygov; Aleksandras Konovalovas; Lon-Fye Lye; Deborah E Dobson; Haroun Zangger; Nicolas Fasel; Anzhelika Butenko; Alexander O Frolov; Jan Votýpka; Claudia M d'Avila-Levy; Pavel Kulich; Jana Moravcová; Pavel Plevka; Igor B Rogozin; Saulius Serva; Julius Lukeš; Stephen M Beverley; Vyacheslav Yurchenko
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-28       Impact factor: 11.205

5.  Leishmania RNA virus controls the severity of mucocutaneous leishmaniasis.

Authors:  Annette Ives; Catherine Ronet; Florence Prevel; Giulia Ruzzante; Silvia Fuertes-Marraco; Frederic Schutz; Haroun Zangger; Melanie Revaz-Breton; Lon-Fye Lye; Suzanne M Hickerson; Stephen M Beverley; Hans Acha-Orbea; Pascal Launois; Nicolas Fasel; Slavica Masina
Journal:  Science       Date:  2011-02-11       Impact factor: 47.728

6.  Muco-cutaneous leishmaniasis in the New World: the ultimate subversion.

Authors:  Catherine Ronet; Stephen M Beverley; Nicolas Fasel
Journal:  Virulence       Date:  2011-11-01       Impact factor: 5.882

7.  Retention and loss of RNA interference pathways in trypanosomatid protozoans.

Authors:  Lon-Fye Lye; Katherine Owens; Huafang Shi; Silvane M F Murta; Ana Carolina Vieira; Salvatore J Turco; Christian Tschudi; Elisabetta Ullu; Stephen M Beverley
Journal:  PLoS Pathog       Date:  2010-10-28       Impact factor: 6.823

8.  Elimination of LRVs Elicits Different Responses in Leishmania spp.

Authors:  Andreu Saura; Alexandra Zakharova; Donnamae Klocek; Evgeny S Gerasimov; Anzhelika Butenko; Diego H Macedo; Elena Servienė; Diana Zagirova; Anastasia Meshcheryakova; Igor B Rogozin; Saulius Serva; Alexei Yu Kostygov; Vyacheslav Yurchenko
Journal:  mSphere       Date:  2022-08-09       Impact factor: 5.029

Review 9.  Leishmania RNA virus: when the host pays the toll.

Authors:  Mary-Anne Hartley; Catherine Ronet; Haroun Zangger; Stephen M Beverley; Nicolas Fasel
Journal:  Front Cell Infect Microbiol       Date:  2012-07-12       Impact factor: 5.293

10.  Leishmaniavirus-Dependent Metastatic Leishmaniasis Is Prevented by Blocking IL-17A.

Authors:  Mary-Anne Hartley; Eliane Bourreau; Matteo Rossi; Patrik Castiglioni; Remzi Onur Eren; Florence Prevel; Pierre Couppié; Suzanne M Hickerson; Pascal Launois; Stephen M Beverley; Catherine Ronet; Nicolas Fasel
Journal:  PLoS Pathog       Date:  2016-09-22       Impact factor: 6.823

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.